Experimental validation of the accuracy of robotic-assisted radioactive seed implantation for tumor treatment.

Abstract

An experimental validation of a robotic system for radioactive iodine-125 seed implantation (RISI) in tumor treatment was conducted using customized phantom models and animal models simulating liver and lung lesions. The robotic system, consisting of planning, navigation, and implantation modules, was employed to implant dummy radioactive seeds into the models. Fiducial markers were used for target localization. In phantom experiments across 40 cases, the mean errors between planned and actual seed positions were 0.98±1.05mm, 1.14±0.62mm, and 0.90±1.05mm in the x, y, and z directions, respectively. The x, y, and z directions correspond to the left-right, anterior-posterior, and superior-inferior anatomical planes. Silicone phantoms exhibiting significantly smaller x-axis errors compared to liver and lung phantoms (p<0.05). Template assistance significantly reduced errors in all axes (p<0.05). No significant dosimetric deviations were observed in parameters such as D90, V100, and V150 between plans and post-implant doses (p>0.05). In animal experiments across 23 liver and lung cases, the mean implantation errors were 1.28±0.77mm, 1.66±0.69mm, and 1.86±0.93mm in the x, y, and z directions, slightly higher than in phantoms (p<0.05), with no significant differences between liver and lung models. The dosimetric results closely matched planned values, confirming the accuracy of the robotic system for RISI, offering new possibilities in clinical tumor treatment.